Acute Gout Flare Clinical Trials
3 recruiting trials for Acute Gout Flare. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 2NCT07145229
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
A randomized, double-blind, international multicenter, colchicine and placebo-controlled study to evaluate the efficacy and safety of ABP-745 in subjects with acute gout. Efficacy...
Sponsor: Atom Therapeutics Co., LtdEnrolling: 38020 locations
RECRUITINGPhase 1NCT07295496
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic of IBI3011
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of recombinant Anti-IL-RAP humanised monoclonal antibody injection in healthy Chinese...
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.Enrolling: 641 location
RECRUITINGPhase 2 / Phase 3NCT05658575
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
The purpose of this trial is to investigate the efficacy and safety of dapansutrile (OLT1177®) tablets in subjects with an acute gout flare.
Sponsor: Olatec Therapeutics LLCEnrolling: 30020 locations